MedPath

EmbryoGlue as an Embryo Transfer Medium

Not Applicable
Conditions
Infertility
Interventions
Biological: EmbryoGlue® (laboratory culture medium)
Biological: Standard control medium
Registration Number
NCT03332680
Lead Sponsor
University of Oxford
Brief Summary

In Vitro Fertilisation (IVF) is an increasingly common treatment for infertility. Clinics which offer IVF are continuously trying to improve their success rates, measured by the numbers of IVF cycles which result in the birth of a live baby.

One factor which is thought to have contributed to the success of IVF is the improvements in the embryo culture media, that is, the fluid in which the embryo resides in the laboratory before being replaced into a woman's womb. This trial seeks to identify if IVF cycles in which a particular culture media called EmbryoGlue is used have better results when compared to IVF cycles in which a conventional embryo transfer media is used.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
730
Inclusion Criteria

• Couples having embryo transfer for fertility treatment

Read More
Exclusion Criteria
  • Cycles in which elective freezing of all embryos is clinically indicated (e.g. severe risk of OHSS, biopsy patients)
  • Use of donor gametes
  • Having endometrial scratch technique this cycle
  • Concurrent participation in clinical trial(s)
  • Previously randomised to this study
  • Planned self-fund of EmbryoGlue as transfer media
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EmbryoGlue® (laboratory culture medium)EmbryoGlue® (laboratory culture medium)laboratory culture medium laboratory embryo culture medium, embryos are placed in this media prior to transfer into uterus via embryo transfer procedure to facilitate IVF. EmbryoGlue contains Hyaluronic acid.
Standard control mediumStandard control mediumlaboratory culture medium In standard procedure embryos are placed in a media prior to transfer into uterus via embryo transfer procedure to facilitate IVF.
Primary Outcome Measures
NameTimeMethod
Live Birth Rateoutcome data up to 9 months after intervention
Secondary Outcome Measures
NameTimeMethod
Implantation rateoutcome data up to 9 months after intervention
Clinical pregnancy rates,outcome data up to 9 months after intervention
Adverse IVF events.outcome data up to 9 months after intervention

Trial Locations

Locations (1)

Oxford Fertility

🇬🇧

Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath